NBIX
NASDAQ HealthcareNeurocrine Biosciences, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
📊 Market Data
| Price | $127.78 |
|---|---|
| Volume | 753,437 |
| Market Cap | 12.82B |
| Beta | 0.360 |
| RSI (14-Day) | 47.6 |
| 200-Day MA | $136.78 |
| 50-Day MA | $133.82 |
| 52-Week High | $160.18 |
| 52-Week Low | $84.23 |
| P/E Ratio | 27.30 |
| Forward P/E | 13.15 |
| Price / Book | 3.93 |
🎯 Investment Strategy Scores
How NBIX scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
46/100
High dividend yield + low volatility
🚀 Moon Shot
15/100
High growth potential (high beta + oversold)
🔪 Falling Knife
44/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
68/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
77/100
Large-cap, institutional-quality stocks
Find NBIX in your text
Paste any text on the homepage — the tool will extract NBIX and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.